Skip to main content
. 2021 Feb 5;9:637737. doi: 10.3389/fbioe.2021.637737

TABLE 1.

Summary of perinatal EVs mechanisms of action and biological effects.

Cell type Model Target cells Key molecules/Molecular mechanism Biological effect References
hUC-MSC Rat hepatic ischemia-reperfusion injury Hepatocytes, Neutrophils Mitochondrial manganese superoxide dismutase Mn(SOD), anti-oxidant activity Decreased expression of inflammatory cytokines in hepatic tissue and serum, decreased hepatocyte necrosis Yao et al. (2019)
hUC-MSC Mouse model of acute liver failure; RAW 264.7 macrophages in vitro activated with LPS Macrophages Inhibition of NLRP3 inflammasome complex expression Reduced caspase 1 and inflammatory cytokines (IL-1β and IL-6) Jiang et al. (2019)
hUC-MSC Mouse model of acute burn Macrophages miR-181c downregulation of TLR-4 receptor expression with consequent downregulation of NF-κB/p65 pathway Reduction of M1 macrophage activation Li et al. (2016)
hUC-MSC Mouse model of aortic aneurysm T lymphocytes miR-147 Decreased expression of inflammatory cytokines, reduction of lymphocytes infiltration, improved aortic diameter, and elasticity Spinosa et al. (2018)
hUC-MSC (LPS primed) Wound healing model in diabetic rat Macrophages miR-let-7b down regulation of TLR4/NF-κB/STAT3/AKT signaling pathway Promotion of M2 macrophage activation, enhanced diabetic cutaneous wound healing Ti et al. (2015)
hUC-MSC (IL-1β primed) Mouse model of sepsis Macrophages miR-146a Increased polarization of macrophages toward the M2 anti-inflammatory subset Song et al. (2017)
hUC-MSC Mouse and rat spinal cord injury model Macrophages - Reduction of inflammatory cytokines and M2 polarization Romanelli et al. (2019); Sun et al. (2018)
hUC-MSC Mouse model of inflammatory bowel disease Macrophages - Reduced macrophage recruitment and reduced inflammation Mao et al. (2017)
hUC-MSC Mouse model of retinal laser injury Macrophages - Downregulation of MCP1 and macrophage infiltration Yu et al. (2016)
hUC-MSC Rat model of experimental autoimmune uveoretinitis CD4 T lymphocytes, NK cells, neutrophils and macrophages - Reduced infiltration of inflammatory immune cells Bai et al. (2017)
hUC-MSC Synthetic vascular grafts in rat model of hyperlipidemia Macrophages - Reduced macrophage infiltration and enhanced M2 macrophage polarization, associated with reduced thrombosis and vascular intimal hyperplasia Wei et al. (2019)
hUC-MSC Alzheimer mouse model Microglia - Reduced number of M1 microglial cells, promotion of M2 microglial polarization associated with reduced neuroinflammation and B amyloid deposition Ding et al. (2018)
hUC-MSC Human in vitro purified T lymphocytes T lymphocytes Adenosine signaling through CD73 expression Reduced T lymphocyte activation Kerkelä et al. (2016)
hUC-MSC Mouse model of contact hypersensitivity T lymphocytes STAT1 signaling pathway inhibition Reduced cytotoxic and Th1 lymphocyte infiltration and induced Treg with reduced tissue swelling Guo et al. (2019)
hUC-MSC Human in vitro purified T lymphocytes T lymphocytes - Reduced T lymphocyte proliferation and inflammatory cytokine production Monguió-Tortajada et al. (2017)
hUC-MSC GVHD mouse model T lymphocytes - Reduced CD8 cytotoxic T lymphocyte and reduced inflammatory cytokines in serum, alleviated GVHD manifestations and reduced mortality of the recipient mice Wang et al. (2016)
hUC-MSC (β2 microglobulin deficient) Rat model of myocardial infarction CD8 T lymphocytes miR-24 Reduced CD8 T lymphocyte cytotoxicity with improved preservation of cardiac function after myocardial infarction Shao et al. (2020)
hUC-MSC (primed with TGFβ and IFNy) In vitro study on human PBMC Treg IDO1 Increased Treg polarization Zhang et al. (2018)
hUC-MSC In vitro study on hUC-MSC and hCB-MSC miRNA profiling miR-a25b, miR26a, miR145, miR181c-5p, miR-Let7e, miR-Let7c, miR-Let7f, and miR.106a miRNAs with immunoregulatory functions Meng et al. (2017)
hUC-MSC Rat model of renal ischemic reperfusion injury NK cells CXC3L1, TLR-2 Reduced CXC3L1 and TLR-2 expression with consequent reduced NK cell recruitment Zou et al. (2016)
hWJ-MSC Mouse model of acute kidney injury Macrophages - Decreased CXCL3 ligand 1, reduced macrophage and T lymphocyte infiltration, and reduced renal injury Zou et al. (2014)
hWJ-MSC Perinatal brain injury rat model Microglia TLR4/CD14 signaling pathway inhibition Reduced expression of inflammatory cytokines by microglial cells Thomi et al. (2019)
hWJ-MSC Mouse model of hyperoxia-induced bronchopulmonary dysplasia (BPD) Neutrophils Tumor necrosis factor alpha-stimulated gene-6 (TSG-6) Suppression of hyperoxia-induced neutrophil accumulation in bronchoalveolar lavage (BAL) with improvement of BPD pathology Chaubey et al. (2018)
canine WJ-MSC In vitro study with canine PBMC CD4 T lymphocytes TGF-β1/Adenosine signaling Reduced CD4 T lymphocyte proliferation Crain et al. (2019)
hWJ-MSC Hyperoxia-induced bronchopulmonary dysplasia Macrophages - Reduced M1 macrophage lung infiltration, enhanced M2 polarization Willis et al. (2018)
hAF-MSC (primed with IFNy) In vitro co-culture with PBMC; mouse model of allogeneic skin graft transplantation Treg IDO1 Increased number of Treg cells promoting in vivo allograft survival Romani et al. (2015)
hAF-MSC In vitro THP1 macrophage cell line; mouse model of monoiodoacetate induced osteoarthritis Macrophages - Promoted skewing of THP1 committed M1 macrophages toward M2 subset. In vivo increased pain tolerance and improved histopathological score Zavatti et al. (2020)
hAF-SC In vitro and in vivo models of skeletal muscle atrophy (HSA-Cre, SmnF7/F7 mice) B lymphocytes - Reduced B lymphocyte maturation and decreased skeletal muscle inflammation associated with enhanced muscle strength and survival Balbi et al. (2017)
hAEC Mouse model of CCl4 induced liver fibrosis Macrophages - Reduced liver fibrosis through promotion of M2 macrophage polarization Alhomrani et al. (2017)
hAEC Bleomycin-induced pulmonary fibrosis Macrophages/T lymphocytes - Reduced lung fibrosis through promotion of M2 macrophage polarization and reduction of T cell infiltration Tan et al. (2018)

hUC-MSC, human umbilical cord mesenchymal stromal cells; hAF-SC, human amniotic fluid stem cells; hAF-MSC, human amniotic fluid mesenchymal stromal cells; hWJ-MSC, human Wharton’s jelly mesenchymal stromal cells; IDO1, indoleamine-2,3-dioxygenase-1; LPS, lipopolysaccharide; TLR-2/4, Toll like receptor 2 or 4; CXC3L1, chemokine (C-X3-C motif) ligand 1; GVHD, acute graft-vs-host disease; NK, natural killer cells; MCP-1, monocyte chemotactic protein-1, PBMC; human peripheral blood mononuclear cells.